세계의 무균 여과 시장 규모 : 제품 유형별, 막 유형별, 기공 크기별, 용도별, 소수성 성별, 최종 용도별 예측(2024-2032년)

Global Sterile Filtration Market will grow at a 9% CAGR from 2024 to 2032. Increasing healthcare expenditure worldwide, especially in emerging markets, is creating a higher demand for sterile filtration products. Additionally, ongoing technological advancements are improving filtration efficiency and product quality. Coupled with frequent new product launches catering to diverse industry needs, these factors will drive substantial growth in the sterile filtration industry, offering enhanced solutions for the pharmaceutical, biotechnology, and healthcare sectors.

For instance, in April 2023, Porvair introduced the Biofil(TM) 3 and Biofil(TM) 3 Plus series, featuring polyethersulfone products tailored for sterile liquid filtration applications.

The is segmented based on product type, membrane type, pore size, application, hydrophobicity, end use, and region.

The biotechnology companies segment will undergo a significant uptick between 2024 and 2032. This dominance stems from their critical role in developing advanced therapies and medicines, necessitating stringent filtration processes for product safety and efficacy. As the demand for biopharmaceuticals continues to surge, these firms are at the forefront of innovation. With a strong emphasis on quality control and regulatory compliance, biotechnology companies will lead the market, highlighting their pivotal position in the healthcare and pharmaceutical sectors.

The sterile filtration market size from the PVDF segment will witness commendable growth through 2032, owing to the exceptional chemical resistance and durability of PVDF membranes, making them ideal for critical filtration processes in the pharmaceutical and biotechnology industries. As demand rises for high-performance filtration solutions, PVDF membranes stand out for their ability to maintain product integrity and meet stringent regulatory requirements. With its wide range of applications and superior performance, the PVDF segment will dominate the sterile filtration industry.

Asia Pacific sterile filtration industry will exhibit a noteworthy CAGR from 2024 to 2032, attributed to robust industrial growth and a burgeoning pharmaceutical landscape. The region's expanding biotech sector, in line with stringent regulatory standards, will propel this ascent. Leading economies such as China and India spearhead the market, fueled by substantial investments in innovation. With applications spanning pharmaceuticals to the food and beverage industries, Asia Pacific will emerge as a pivotal contributor to the market expansion.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Base estimates & calculations
• 1.3 Data collection
• 1.4 Forecast parameters
• 1.5 Data validation
• 1.6 Data sources
  • 1.6.1 Primary
  • 1.6.2 Secondary
    • 1.6.2.1 Paid sources
    • 1.6.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing demand for sterile filtration in drug development
    • 3.2.1.2 Technological advancements
    • 3.2.1.3 Increasing concern for infection prevention and control measures
    • 3.2.1.4 Rising private and public investment in research and development
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Stringent regulatory guidelines
    • 3.2.2.2 High cost of sterile filters
• 3.3 Growth potential analysis
• 3.4 Porter's analysis
  • 3.4.1 Supplier power
  • 3.4.2 Buyer power
  • 3.4.3 Threat of new entrants
  • 3.4.4 Threat of substitutes
  • 3.4.5 Industry rivalry
• 3.5 PESTEL analysis
• 3.6 Pricing analysis, 2023
• 3.7 Regulatory landscape
• 3.8 Technological landscape
• 3.9 Future market trends

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2018 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Filters
  • 5.2.1 Membrane filters
  • 5.2.2 Cartridge filters
  • 5.2.3 Capsule filters
  • 5.2.4 Syringe filters
  • 5.2.5 Bottle-top filters
  • 5.2.6 Other filter types
• 5.3 Accessories

Chapter 6 Market Estimates and Forecast, By Membrane Type, 2018 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Polyethersulfone (PES)
• 6.3 Polyvinylidene fluoride (PVDF)
• 6.4 Nylon
• 6.5 Polytetrafluoroethylene polymer (PTFE)
• 6.6 Mixed cellulose esters (MCE)
• 6.7 Other membrane types

Chapter 7 Market Estimates and Forecast, By Pore Size, 2018 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 <0.1μm
• 7.3 0.1 - 0.22μm
• 7.4 0.45 - 1μm
• 7.5 >1μm

Chapter 8 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Bioprocess
• 8.3 Raw material filtration
• 8.4 Prefilteration
• 8.5 Active pharmaceutical ingredient filtration
• 8.6 Final product processing
• 8.7 Other applications

Chapter 9 Market Estimates and Forecast, By Hydrophoicity, 2018 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 Hydrophilic membrane
• 9.3 Hydrophobic membrane

Chapter 10 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

• 10.1 Key trends
• 10.2 Pharmaceutical companies
• 10.3 Biotechnology companies
• 10.4 Food & beverage companies
• 10.5 CMOs & CROs
• 10.6 Other end-users

Chapter 11 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

• 11.1 Key trends
• 11.2 North America
  • 11.2.1 U.S.
  • 11.2.2 Canada
• 11.3 Europe
  • 11.3.1 Germany
  • 11.3.2 UK
  • 11.3.3 France
  • 11.3.4 Spain
  • 11.3.5 Italy
  • 11.3.6 Rest of Europe
• 11.4 Asia Pacific
  • 11.4.1 China
  • 11.4.2 Japan
  • 11.4.3 India
  • 11.4.4 Australia
  • 11.4.5 South Korea
  • 11.4.6 Rest of Asia Pacific
• 11.5 Latin America
  • 11.5.1 Brazil
  • 11.5.2 Mexico
  • 11.5.3 Argentina
  • 11.5.4 Rest of Latin America
• 11.6 Middle East and Africa
  • 11.6.1 South Africa
  • 11.6.2 Saudi Arabia
  • 11.6.3 UAE
  • 11.6.4 Rest of Middle East and Africa

Chapter 12 Company Profiles

• 12.1 3M Company
• 12.2 Alfa Laval
• 12.3 Cobetter Filtration Equipment Co. Ltd.
• 12.4 Corning Incorporated
• 12.5 Danaher Corporation
• 12.6 GE Healthcare
• 12.7 Merck KGaA
• 12.8 Parker Hannifin Corporation
• 12.9 Porvair Filtration Corp
• 12.10 Sartorius AG
• 12.11 Sterlitech Corporation